Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

ERS and ISAM: a significant progression

P. Diot, W. MacNee, W. Kreyling, R. Dahl, B. Laube, G. Viegi
Breathe 2005 2: 123-124; DOI: 10.1183/18106838.0202.123
P. Diot
1President Elect
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. MacNee
2President Elect
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Kreyling
3Past President
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Dahl
4Past President
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Laube
5President of the International Society for Aerosols in Medicine (ISAM; )
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Viegi
6President of the European Respiratory Society (ERS; )
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Extract

For decades, the concept of administering drugs directly into the bronchial tree, in the form of aerosols, has been the cornerstone of therapy in pneumology. Spray technology was initially developed in the middle of the 19th century, but the concept of aerosol therapy was really born with the discovery of adrenaline and epinephrine at the beginning of the 20th century. According to a paper published in 1936 [1], the first case of asthma treated with aerosolised adrenaline was reported in 1912. Pictures dating from this era illustrate the kinds of materials that were used, probably resulting in dissemination of the drugs more around the patient than in the respiratory tract itself [2]! However, even with such poor technical conditions, bronchodilation with β-agonists was so efficient that it stimulated technological research, leading to the design of metered-dose inhalers in the early 1950s. From that time, aerosol therapy became the subject of active research both in the field of devices, with the development of ultrasonic and jet nebulisers in the 1950s, and in the field of formulations, leading to the discovery of new drugs such as beclomethasone, which revolutionised the treatment of asthma in the early 1970s.

  • ©ERS 2005

Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

PreviousNext
Back to top
Vol 2 Issue 2 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
ERS and ISAM: a significant progression
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
ERS and ISAM: a significant progression
P. Diot, W. MacNee, W. Kreyling, R. Dahl, B. Laube, G. Viegi
Breathe Dec 2005, 2 (2) 123-124; DOI: 10.1183/18106838.0202.123

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
ERS and ISAM: a significant progression
P. Diot, W. MacNee, W. Kreyling, R. Dahl, B. Laube, G. Viegi
Breathe Dec 2005, 2 (2) 123-124; DOI: 10.1183/18106838.0202.123
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Pulmonary vascular disease for the general respiratory clinician
  • Sleep medicine in Europe: 50 years of evolution
  • Managing respiratory disease in pregnancy
Show more Editorials

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society